Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

México Noticias Noticias

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
México Últimas Noticias,México Titulares
  • 📰 Forbes
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

I am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.

Who Is Potential Biden Primary Challenger Dean Phillips? Millionaire Former Gelato Exec Turned Congressman Would Be President’s Most Prominent OpponentStocks of Pfizer and other Covid vaccine makers like BioNTech and Moderna fell in premarket trading Monday after the company slashed its revenue forecasts last week, a change in fortune for the sector as demand for the pandemic-related products that propelled them to record profits last year plummets.

by 13% on Friday due to sliding demand for its Covid-19 products. Sales of the firm’s mRNA shot, produced jointly with BioNTech, and its antiviral drug Paxlovid helped it secure record profits last year but the firm hasits projections for Paxlovid by $7 billion and by around $2 billion for its Covid shots, which was greater than analystsit was launching a $3.5 billion cost-cutting program covering jobs and expenses as it prepares for the hit to its revenues.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Forbes /  🏆 394. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandVaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Leer más »

Top Wall Street analysts believe in the long-term potential of these stocksTop Wall Street analysts believe in the long-term potential of these stocksTipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Meta.
Leer más »

Top Wall Street analysts believe in the long-term potential of these stocksTop Wall Street analysts believe in the long-term potential of these stocksTipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Meta.
Leer más »

Top Wall Street analysts believe in the long-term potential of these stocksTop Wall Street analysts believe in the long-term potential of these stocksTipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Meta.
Leer más »

Stock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester UnitedStock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester UnitedLululemon stock climbs ahead of S&P 500 inclusion
Leer más »

1 Stock to Buy, 1 Stock to Sell This Week: Lululemon, Pfizer1 Stock to Buy, 1 Stock to Sell This Week: Lululemon, PfizerStocks Analysis by Investing.com (Jesse Cohen) covering: Pfizer Inc, Lululemon Athletica Inc. Read Investing.com (Jesse Cohen)'s latest article on Investing.com
Leer más »



Render Time: 2025-02-28 18:59:23